Artemis Medicare Services Limited has informed the Exchange about Investor Presentation
ARTEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Artemis Medicare Services reported strong Q4 FY26 and full year FY26 results. Consolidated revenue grew 15.4% YoY to INR 1,081 Cr, with EBITDA up 18% to INR 218 Cr and PAT rising 26.2% to INR 104 Cr. EBITDA margin expanded by 44 bps to 20.2%, showing positive margin improvement. The Gurgaon hospital (700 beds) saw IP volumes grow 9.6% to 34,428 and ARPOB increase 7.8% to INR 82,435. The company disclosed expansion plans including a 300+ bed Raipur hospital (expected May/June 2026), a 650+ bed South Delhi facility (FY29), and a 110-bed Mauritius facility (FY27), targeting ~2,000 beds by 2028. The organization also proposes to raise ~INR 700 crore to support growth capital requirements.
Strong operational performance with margin expansion and clear multi-year expansion roadmap signals solid execution. The planned INR 700 crore capital raise may have dilution implications but supports the growth trajectory outlined in the multi-year expansion plan.